Literature DB >> 14704594

Enhancement of myocardial vulnerability by atrial fibrillation.

John C Somberg1, Vilma Torres, Gad Keren, Brenda Butler, David Tepper, Herman Kleinbaum, Janos Molnar.   

Abstract

Certain groups are known to have an increased risk for sudden cardiac death. Epidemiologic studies have suggested that patients with atrial fibrillation may be at higher risk. The authors hypothesize that atrial fibrillation may increase myocardial vulnerability. To test this hypothesis, 37 dogs were studied using programmed electrical stimulation techniques to determine myocardial vulnerability as assessed by the ability to provoke ventricular tachycardia. Prior to atrial fibrillation, programmed electrical stimulation did not induce ventricular tachycardia. Aconitine was then topically applied to the right atrial appendage with care taken not to make contact with the ventricle. Application of aconitine caused atrial fibrillation with an increase in ventricular rate, but did not affect arterial blood pressure. Ventricular tachycardia was induced by programmed electrical stimulation studies in 25 of 26 dogs in atrial fibrillation. The enhanced vulnerability was noted following atrial fibrillation, not after aconitine application to the great veins, which did not cause atrial fibrillation. To further exclude the possibility that aconitine application may cause changes in ventricular threshold, atrial fibrillation was induced by pacing techniques in five dogs. Prior to atrial fibrillation induction, programmed electrical stimulation did not induce ventricular tachycardia. Following atrial fibrillation, ventricular tachycardia could be repeatedly induced. Mean heart rate following atrial fibrillation increased, while pacing animals at this increment in rate did not change the noninducibility of dogs in sinus rhythm. Six patients with a history of atrial fibrillation and ventricular tachycardia were studied to determine if AF lowered myocardial threshold to VT induction. Ventricular tachycardia could only be induced by PES techniques in four of five patients when the patients' rhythm was AF (P < 0.05). This study suggests that atrial fibrillation lowers myocardial threshold for ventricular tachycardia induction and thus enhances myocardial vulnerability. The association of AF with a higher incidence of sudden death may be due to an enhanced electrical instability.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14704594     DOI: 10.1097/00045391-200401000-00009

Source DB:  PubMed          Journal:  Am J Ther        ISSN: 1075-2765            Impact factor:   2.688


  4 in total

1.  Atrial fibrillation and the risk of sudden cardiac death: the atherosclerosis risk in communities study and cardiovascular health study.

Authors:  Lin Y Chen; Nona Sotoodehnia; Petra Bůžková; Faye L Lopez; Laura M Yee; Susan R Heckbert; Ronald Prineas; Elsayed Z Soliman; Selcuk Adabag; Suma Konety; Aaron R Folsom; David Siscovick; Alvaro Alonso
Journal:  JAMA Intern Med       Date:  2013-01-14       Impact factor: 21.873

2.  New-onset atrial fibrillation is associated with cardiovascular events leading to death in a first time myocardial infarction population of 89,703 patients with long-term follow-up: a nationwide study.

Authors:  Casper N Bang; Gunnar H Gislason; Anders M Greve; Christian A Bang; Alexander Lilja; Christian Torp-Pedersen; Per K Andersen; Lars Køber; Richard B Devereux; Kristian Wachtell
Journal:  J Am Heart Assoc       Date:  2014-01-21       Impact factor: 5.501

3.  Prevalence of sudden cardiac death in dogs with atrial fibrillation.

Authors:  Kieran Borgeat; Matthew Pack; Jo Harris; Alex Laver; Joonbum Seo; Omri Belachsen; Joshua Hannabuss; Julie Todd; Luca Ferasin; Jessie Rose Payne
Journal:  J Vet Intern Med       Date:  2021-11-09       Impact factor: 3.333

4.  Atrial Fibrillation Is Associated with Increased Mortality in Patients Presenting with Ventricular Tachyarrhythmias.

Authors:  Michael Behnes; Jonas Rusnak; Gabriel Taton; Tobias Schupp; Linda Reiser; Armin Bollow; Thomas Reichelt; Niko Engelke; Dominik Ellguth; Philipp Kuche; Siegfried Lang; Christoph A Nienaber; Kambis Mashayekhi; Muharrem Akin; Thomas Bertsch; Dennis Ferdinand; Christel Weiss; Martin Borggrefe; Ibrahim Akin
Journal:  Sci Rep       Date:  2019-10-03       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.